Literature DB >> 26836462

Association of occlusal interference-induced masseter muscle hyperalgesia and P2X3 receptors in the trigeminal subnucleus caudalis and midbrain periaqueductal gray.

Shuzhen Sun1, Dong Qi, Yingying Yang, Ping Ji, Jingjing Kong, Qingting Wu.   

Abstract

P2X3 receptor plays a role in nociception transmission of orofacial pain in temporomandibular disorder patients. A previous study found that P2X3 receptors in masseter muscle afferent neurons and the trigeminal ganglia were involved in masseter muscle pain induced by inflammation caused by chemical agents or eccentric muscle contraction. In this study, we attempted to investigate changes in P2X3 receptors in the trigeminal subnucleus caudalis (Vc) and midbrain periaqueductal gray (PAG) in relation to the hyperalgesia of masseter muscles induced by occlusal interference. Experimental occlusal interference by crown application was established in 30 rats and another 30 rats were treated as sham controls. On days 1, 3, 7, 14, and 28 after crown application, the mechanical pain threshold was examined by von-Frey filaments. The expression of the P2X3 receptor in Vc and PAG was investigated by immunohistochemistry and quantitative PCR. We found that mechanical pain threshold of bilateral masseter muscles decreased significantly after occlusal interference, which remained for the entire experimental period. The mRNA expression of the P2X3 receptor increased significantly and the number of P2X3R-positive neurons increased markedly in Vc and PAG accordingly. These results indicate that the upregulated expression of P2X3 receptors in Vc and PAG may contribute toward the development of orofacial pain induced by occlusal interference and P2X3 receptors in the PAG may play a key role in the supraspinal antiociception effect.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26836462     DOI: 10.1097/WNR.0000000000000533

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

1.  [Electrophysiological monitoring of pain afferent pathway of the trigeminal nerve and its functional plasticity in response to occlusal interference in rats].

Authors:  Yun Wang; Jinping Qian; Yaru Gu; Chuanjun Chen; Mengya Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-10-30

2.  Neuronal activities in the rostral ventromedial medulla associated with experimental occlusal interference-induced orofacial hyperalgesia.

Authors:  Si-Yi Mo 莫思怡; Xiao-Xiang Xu 徐啸翔; Shan-Shan Bai 白珊珊; Yun Liu 刘云; Kai-Yuan Fu 傅开元; Barry J Sessle; Ye Cao 曹烨; Qiu-Fei Xie 谢秋菲
Journal:  J Neurosci       Date:  2022-06-03       Impact factor: 6.709

Review 3.  Central Sensitization-Based Classification for Temporomandibular Disorders: A Pathogenetic Hypothesis.

Authors:  Annalisa Monaco; Ruggero Cattaneo; Maria Chiara Marci; Davide Pietropaoli; Eleonora Ortu
Journal:  Pain Res Manag       Date:  2017-08-28       Impact factor: 3.037

4.  The role of P2X3 receptors in bilateral masseter muscle allodynia in rats.

Authors:  Petra Tariba Knežević; Robert Vukman; Robert Antonić; Zoran Kovač; Ivone Uhač; Sunčana Simonić-Kocijan
Journal:  Croat Med J       Date:  2016-12-31       Impact factor: 1.351

5.  Neurotropin alleviates rat osteocarcinoma pain via P2X3 receptor activation in the midbrain periaqueductal gray.

Authors:  Xingfeng Liu; Jingxin He; Zhi Xiao
Journal:  Iran J Basic Med Sci       Date:  2021-10       Impact factor: 2.699

6.  Headache Attributed to Temporomandibular Disorder and Primary Cough Headache.

Authors:  Keita Takizawa; Kentaro Urata; Rena Tanaka; Kana Ozasa; Andrew Young; Noboru Noma
Journal:  Neurol Int       Date:  2022-01-17

7.  Celecoxib in the treatment of orofacial pain and discomfort in rats subjected to a dental occlusal interference model.

Authors:  Andrea Whitehurst Ary Leitão; Marcela Maria Fontes Borges; Joyce Ohana de Lima Martins; Antônio Alexandre Coelho; Anna Clara Aragão Matos Carlos; Ana Paula Negreiros Nunes Alves; Paulo Goberlânio de Barros Silva; Fabrício Bitu Sousa
Journal:  Acta Cir Bras       Date:  2022-08-15       Impact factor: 1.564

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.